Regeneus Progenza - Cryopreserved Multi-Synergistic Therapy Targeting Pain and Inflammation
From Technologies
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic).
-
Most popular related searches
Product Details
A multi-synergistic therapy
Progenza is a cellular therapy targeting pain and inflammation which uses Secretome to improve not only the resident tissue, but the Mesenchymal Signalling Cells (MSCs) themselves. Using the Secretome with the MSCs provides a platform to enhance the MSCs’ potency and efficacy as a cryopreserved injectable.
Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic).
Point of Difference
Progenza™ fills a gap in the current treatment market for osteoarthritis by providing disease modification and pain relief to address patient symptoms – before more drastic treatments such as surgery, are required.
Currently, there are no treatments for osteoarthritis when it comes to disease modification. While there are many options for pain relief for osteoarthritis – including opioid drugs – they only treat the symptoms, not the cause of pain. Many pain relief treatments are also associated with addiction and dependence.
Mechanism of Action
MSCs are immune evasive, meaning they lack immune system identifiers. This allows them to enter a patient’s body and immune system relatively undetected.
When MSCs enter the inflamed environment within a patient’s body, they are activated and alter the phenotype of inflammatory immune cells. This switches the cells into anti-inflammatory, thereby addressing inflammation at its source.
Once at the site of injury, Progenza™ interacts with inflammatory immune cells and downregulates pain-causing signals. Progenza™ also acts to repair local damaged tissue, such as cartilage tissue commonly found in joints like knees and elbows.
Customer reviews
No reviews were found for Regeneus Progenza - Cryopreserved Multi-Synergistic Therapy Targeting Pain and Inflammation. Be the first to review!